Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...

Olipop, a functional prebiotic soda brand (and DWT client), raised $50 million at a $1.85 billion valuation in its latest funding round. The round ...

Q4 2024 Earnings Call Transcript February 13, 2025 Gogoro Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, ...

Welcome to the Gogoro Inc 2024 fourth quarter and full year earnings call. This conference call is now being recorded and broadcasted live over the internet. Webcast replay will be available within an ...

The President of the Interior Designers and Decorators Association of Ghana (IDDG), Audrey Forson, has underscored the importance of industry collaboration in bridging the gap between academic ...

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...

Cardiovascular health supplements address global CVD prevalence, featuring Omega-3s, CoQ10, and plant sterols. Production spans the US, Europe, and A ...

In what feels like a ‘make or break’ year in the ‘Wine Paris and/or Prowein’ debate, Lucy Britner brings readers key trends ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Case-Based Session: Management of ...

Fueled by frustration with toxic work environments and poor leadership, revenge quitting—or abruptly leaving a job to make a statement or highlight dissatisfaction—is becoming an unsettling trend in ...

Emil Kakkis; President, Chief Executive Officer, Director; Ultragenyx Pharmaceutical Inc Erik Harris; Executive Vice President, Chief Commercial Officer; Ultragenyx Pharmaceutical Inc Howard Horn; ...

On March 18 th Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will be giving an oral presentation in the first session dedicated to OPMD at the 2025 Muscular ...